MEDICINE ECONOMY

We know the complex of supplying the demand of treatments with orphan drugs, basically that which it is not produced
in the country.

We know the medical damages that involve the delay of provision, the complications in the treatment and the deterioration of the patient and the additional economical costs to the health system.

If we succeeded in conjugating and shorten the times between the diagnosis and the provision of the treatment, we are contributing with the fundamental beginning of the medicine-economy. In order to do it we put all our work team.
Veresne assumes that Internet is a medium of global communication; however, the pharmaceutical industry is subject to the regulatory frame, specific of each country.